N-TRACK
01 Oct 17
nTRACK Multimodal nanoparticles for structural and functional tracking of stem cell therapy on muscle regeneration www.n-track.eu Cell therapy offers promising
nTRACK Multimodal nanoparticles for structural and functional tracking of stem cell therapy on muscle regeneration www.n-track.eu Cell therapy offers promising
Grant from the European Union’s Horizon 2020 programme awarded to the nTRACK project, designed to study multimodal nanoparticles for structural
The objective of CIMTI is to highlight innovation of the health and social system by promoting projects that have a
The AMICE project is starting today and is having its first meeting hosted by the Technical University of Chemnitz. During
The opening of calls for the Social Challenge Work Program 1 for the years 2018 to 2020 of Horizon 2020
This workshop organised by the GLAM project aims at bringing together experts from the field of photonics, nanomedicine, micro-nano-bio systems
The research project Nano4Derm will focus on the development of innovative formulations containing nanoencapsulated active ingredients for the treatment of
QUIROFAM Transformation of the surgery practice by the incorporation of the additive fabrication ABSTRACT The objective of the project is
The high level of excellence at Catalan research centers is well-known; however, innovation often fails to reach the market. “Very
Welcome to the first HYPOSENS newsletter! HYPOSENS aims at developing a minimally invasive system for better, faster, simpler and cheaper
This workshop organised by the GLAM project aims at bringing together experts from the field of nanotechnologies, photonics and micro-and
The second newsletter has been published! Find information about recent activities and meetings about GLAM such as the first version
From the 13th to the 15th of May, the XXVI International Conference on Sports Rehabilitation and Traumatology will take place
Last week, LEITAT participated in the HEALTHIO event that took place from May 3-5. LEITAT is at the forefront in
Welcome to the first edition of the BATCure Newsletter. Our goal is to keep you informed about progress on the
La efectividad limitada de los tratamientos aprobados, así como las evidencias de sus resistencias y toxicidades, enfatizan la necesidad del
Sede Central Leitat
C/ de la Innovació, 2
08225 Terrassa, (Barcelona)
Tel. (+34) 937 882 300
